EUROLYSE IVS: Financial statements 2018
CVR: 36462191
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2018 report amounted to DKK 100. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 0 | 0 | 100 | - |
| 2017 | - | 0 | 0 | 100 | - |
| 2016 | - | 0 | 0 | 100 | - |
| 2015 | - | 0 | 0 | 100 | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
EUROLYSE IVS has published its annual report for 2017. Gross profit came to DKK 0, and the net result was DKK 0.
About EUROLYSE IVS
EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.